FDA Recall D-0235-2026
Golden State Medical Supply Inc. · Camarillo, CA
Class II Ongoing 169 days on record
Moderate impact — Class II recall — temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.
Product
Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-10
Reason for recall
Presence of Foreign Tablets/Capsules
Recall record
- Recall number
D-0235-2026- Classification
- Class II
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Letter
- Distribution
- Nationwide within the USA
- Recall initiated
- 2025-11-26
- Classified by FDA Center
- 2025-12-15
- FDA published
- 2025-12-24
- Recalling firm
- Golden State Medical Supply Inc.
- Firm location
- Camarillo, CA
Drug identification
- Brand name(s)
- BACLOFEN
- Generic name(s)
- BACLOFEN
- Manufacturer(s)
- Golden State Medical Supply, Inc.
- NDC(s)
51407-972, 51407-973, 51407-974- Route(s)
- ORAL
Operational response
Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.
For the official FDA enforcement record, see FDA's Recall Search.